Angelman syndrome

Search Trials
Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy – ACE Inhibitor Therapy Trial
Status:
Completed
Last Changed:
May 4, 2015
First Changed:
May 4, 2015
Disease(s):
Myocardial Fibrosis
Intervention(s):
Enalapril
The Study of Skeletal Muscle Blood Flow in Becker Muscular Dystrophy
Status:
Terminated
Last Changed:
Jan 14, 2020
First Changed:
Jan 12, 2016
Disease(s):
Muscular Dystrophy
Intervention(s):
Tadalafil 20 MGbeetroot juice extract
Mother-caregivers of Children With Duchenne Muscular Dystrophy
Status:
Completed
Last Changed:
Feb 3, 2016
First Changed:
Aug 13, 2013
Disease(s):
Other Diseases or Conditions
Intervention(s):
sleep parametersHormonal profileInflammatory profileCardiovascular profileMetabolic profile
Dietary Supplements for the Treatment of Angelman Syndrome
Status:
Completed
Last Changed:
Sep 24, 2012
First Changed:
Jul 6, 2006
Disease(s):
Angelman Syndrome
Intervention(s):
BetaineCreatineMetafolinVitamin B12
Angelman Syndrome (AS) Biomarker Study
Status:
Completed
Last Changed:
Jan 28, 2022
First Changed:
Sep 25, 2019
Disease(s):
Angelman Syndrome
Intervention(s):
Lumbar PunctureBlood Collection
A Study of OV101 in Individuals With Angelman Syndrome (AS)
Status:
Completed
Last Changed:
Nov 17, 2020
First Changed:
Sep 27, 2019
Disease(s):
Primary Disease or Condition Being Studied: Angelman Syndrome (AS)
Intervention(s):
GaboxadolPlacebo
Characterization of Angelman Syndrome
Status:
Completed
Last Changed:
Mar 2, 2021
First Changed:
Feb 27, 2006
Disease(s):
Angelman Syndrome
Study on Tolerability of Levodopa/Carbidopa in Children With Angelman Syndrome
Status:
Completed
Last Changed:
Nov 21, 2016
First Changed:
Jan 27, 2009
Disease(s):
Angelman Syndrome
Intervention(s):
Levodopa/Carbidopa (4:1)

Connect. Empower. Inspire.